Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published-Ahead-of-Print April 17, 2008, DOI:10.2164/jandrol.108.004952

This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
29/5/580    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Resmini, E.
Right arrow Articles by Ferone, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Resmini, E.
Right arrow Articles by Ferone, D.

Leptin, Ghrelin, and Adiponectin Evaluation in Transsexual Subjects During Hormonal Treatments

Eugenia Resmini *, Gabriella Andraghetti , Alberto Rebora , Renzo Cordera , Lara Vera , Massimo Giusti , Francesco Minuto , and Diego Ferone

* To whom correspondence should be addressed. E-mail: resminieugenia{at}libero.it.

Gender differences in adiponectin, leptin and ghrelin levels have been described in normal population. This is important for understanding differences between males and females in the regulation of food intake, weight gain, body fat distribution and cardiovascular risk. It is unclear how endogenous and exogenous sex hormones may regulate circulating levels of these factors. Transsexuals during hormonal treatment may represent an ideal model to ascertain role of exogenous sex hormones on these parameters. To evaluate adiponectin, ghrelin and leptin levels in transsexual subjects during hormone therapy and to compare the results with males and females. Subjects: 26 non diabetic transsexuals, 15 male-to-female (M-to-F, group 3), and 11 female-to-male (F-to-M, group 4) and 29 age- BMI-matched controls, 15 males (group 1) and 14 females (group 2). Leptin levels were significantly lower in group 1 compared with group 2 (P=0.04), and group 3 (P=0.01), no differences were recorded between the other groups. Adiponectin levels were significantly higher in group 3 compared with group 4 (P=0.03). No differences were found between the four groups for ghrelin levels. Our data confirm the sexual dimorphism in serum leptin levels in normal subjects and demonstrate an increase in M-to-F. While ghrelin does not show any sexual differences and it seems not influenced by exogenous sex hormone administration, the lower adiponectin levels in F-to-M during treatment confirm that androgens may decrease plasma adiponectin levels. This latter observation suggests that F-to-M transsexual patients could have a higher cardiovascular risk.


Key words: Leptin • adiponectin • cardiovascular risk • ghrelin • transsexuals






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by The American Society of Andrology.